Featured Products
-
Adaptive Trial Design and Implementation
10/31/2018
Cytel brings its expertise in adaptive designs to the design and implementation of the industry’s most innovative clinical trials. These highly flexible trials raise peculiar challenges for enrollment, data collection and regulatory submission. Why not have the industry leaders in adaptive design working on your adaptive trials?
-
Strategic Regulatory Consulting & Planning
1/25/2024
Applying experience, knowledge, and insights to plan and implement regulatory strategies for successful interactions with the FDA, MHRA, EMA, and other Global Regulatory Agencies.
-
Revvity Signals Software Signals™ Medical Review
8/28/2017
See our exciting new solution for medical monitors, Revvity Signals Software Signals™ Medical Review which empowers clinical development teams and medical monitors to detect safety signals faster and reduce time to submission by combining innovative medical review workflow with advanced analytics.
-
Pharmacovigilance Solutions
3/20/2024
Free your safety and clinical teams to focus on what matters most.
-
Why TrialKit PACS?
2/22/2024
New to the TrialKit platform, TrialKit PACS enables researchers to access, engage with, and oversee clinical trial imaging seamlessly within the same system utilized for managing all other study data.
-
EHR-To-EDC Integration
2/27/2023
Discover why more life science teams are using OpenClinica Unite™ to automate source data acquisition from patient medical record systems to clinical trial research databases and case report forms.
-
Patient Engagement
1/29/2018
WCG’s end-to-end patient recruitment solution connects patients to clinical trials, enhances site resources and capabilities, and improves study data quality and endpoints. On average, we are helping our clients achieve a 33% acceleration in their enrollment timelines.
-
Suite Success For Life Science Organizations
9/13/2021
Leverage Sikich’s experience gained from dozens of NetSuite implementations for Life Sciences organizations, just like yours, to avoid common pitfalls and pave your way to success.
-
Multitherapeutic Limitations: Knowing How To Choose The Right Resource
7/20/2021
Chief medical officers looking for outsourcing services on a study are often fed lines from large CROs on how they can provide individuals with multitherapeutic backgrounds.
-
End-To-End Ophthalmic Drug Development Solutions
4/9/2024
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions support programs from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.